Berlin Conference on Novel Antimicrobials

Big drugs for bad bugs

Over its ten-year history, the Berlin Conference on Life Sciences has become a must-attend event for Life Science decision makers, business developers, investors and legal experts. The 10th Berlin Conference explored the exciting market and challenging conditions for the development of novel antimicrobials.

• Antimicrobial Market – Industry overview, SME engagement & financial insights
• Technology Perspective– New approaches to efficiently combat antimicrobial resistance
• Legal Environment & Reimbursment– The challenges of bringing antimicrobials to the market
• R&D Trends – Research and development beyond antibiotics & public-private partnerships
• Start-up Pitch – Investors talk & new business models in the field
  
  

Speakers covered the entire value chain from research & development to the market. Please see the next page for the programme.

Picture gallery on flickr